Preemptive Targeting of Preleukemic Cells in Down Syndrome with Pathway-Directed Therapies
Klinische Pädiatrie · 01.05.2024 · 236 (03) · 213
DOI: 10.1055/s-0044-1786619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.05.2024. Verfasst von A L Schmell und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Preemptive Targeting of Preleukemic Cells in Down Syndrome with Pathway-Directed Therapies
Zitieren
APA
Schmell, A. L., Meier, K., Alejo-Valle, O., Issa, H., Benhassine, K., Schuschel, K., Heckl, D., Bhayadia, R., & Klusmann, J. H. (2024). Preemptive Targeting of Preleukemic Cells in Down Syndrome with Pathway-Directed Therapies. Klinische Pädiatrie, 236(03), 213. https://doi.org/10.1055/s-0044-1786619
Vancouver
Schmell AL, Meier K, Alejo-Valle O, Issa H, Benhassine K, Schuschel K, et al. Preemptive Targeting of Preleukemic Cells in Down Syndrome with Pathway-Directed Therapies. Klinische Pädiatrie. 2024;236(03):213. doi:10.1055/s-0044-1786619
BibTeX
@article{Schmell2024,
author = {Schmell, A L and Meier, K and Alejo-Valle, O and Issa, H and Benhassine, K and Schuschel, K and Heckl, D and Bhayadia, R and Klusmann, J H},
title = {Preemptive Targeting of Preleukemic Cells in Down Syndrome with Pathway-Directed Therapies},
journal = {Klinische Pädiatrie},
year = {2024},
volume = {236},
number = {03},
pages = {213},
doi = {10.1055/s-0044-1786619}
}
EUVIMED